By vgreene, 15 January, 2015 Cath ablation<sup>31</sup> + peri-ablation anticoagulation<sup>29</sup> is an option; factor risk/benefit, pt preference.
By vgreene, 15 January, 2015 If undergoing cardiac surgery for other reasons: maze procedure reasonable for select pts<sup>31</sup> [IIa/C]
By vgreene, 15 January, 2015 Cath ablation of accessory pathway recommended for pre-excited AF<sup>31</sup> [I/C]
By vgreene, 15 January, 2015 Cath ablation<sup>31</sup> for persistent AF w/ sx reasonable if refractory/intolerant to ≥1 class I/III drug [IIa/A], consider for long-standing (>12 mo) persistent AF w/ sx [IIb/B]; consider as initial strategy before class I/III drug trial [IIb/B]
By vgreene, 15 January, 2015 Cath ablation<sup>31</sup> for paroxysmal AF w/ sx: useful if refractory/intolerant to ≥1 class I/III drug [I/A]; reasonable as initial strategy before class I/III drug trial for recurrent paroxysmal AF w/ sx [IIa/B]
By vgreene, 15 January, 2015 Restore sinus rhythm<sup>26</sup> via DC cardioversion, antiarrhythmic drug, or RF cath ablation; +/- rate control. Correct underlying causes [I/C].
By vgreene, 15 January, 2015 Postconversion maintenance drug options<sup>30</sup> based on CAD/LVH/HF, comorbidities, drug risks [I/A], +/- rate-control tx. OK to continue antiarrhythmic despite infrequent, well-tolerated, recurrences [IIb/C]; stop if AF becomes permanent [III/B]
By vgreene, 15 January, 2015 Postconversion pill-in-pocket prn option: propafenone/flecainide + BB/non-DHB-CCB (diltiazem/verapamil), once proven safe in monitored setting, reasonable to terminate out-pt AF [IIa/B]
By vgreene, 15 January, 2015 Pharmacologic cardioversion<sup>30</sup> + peri-procedural anticoagulation<sup>29</sup> + rate-control tx: flecainide, dofetilide, propafenone, IV ibutilide [I/A] or amiodarone<sup>31</sup> [IIa/A]